image
Madrigal Pharmaceuticals, Inc. MDGL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 300.27
-2.2 %
$ 6.63 B
Market Cap
-13.47
P/E
Price Target Average
26.89%
Revenue Forecast Estimate
117.64%
EBIT Estimate
61.90%
Net Income Estimate
58.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Madrigal Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for MDGL of $381 , with forecasts ranging from a low of $336 to a high of $410 .
MDGL Lowest Price Target Wall Street Target
336 USD 11.90%
MDGL Average Price Target Wall Street Target
381 USD 26.89%
MDGL Highest Price Target Wall Street Target
410 USD 36.54%
Price
Max Price Target
Min Price Target
Average Price Target
450450400400350350300300250250200200Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart MDGL

image
$4.5b$4.5b$4.0b$4.0b$3.5b$3.5b$3.0b$3.0b$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.0201920192020202020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart MDGL

image
$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.0($500.0m)($500.0m)201920192020202020232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart MDGL

image
$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.0($500.0m)($500.0m)($1.0b)($1.0b)201920192020202020232023202420242025202520262026202720272028202820292029